Physicians across specialties reported an average of 40 prior authorizations per week and roughly 13 hours spent processing them, according to AMA's 2025 survey. Nearly all respondents said authorization delayed care. For infectious disease, where treatment duration, site-of-care decisions, and specialty drug costs stack on top of each other, the stakes are higher.
This article compares five authorization platforms and workflow tools, explains what each one actually does, and walks through how to evaluate payer coverage, documentation support, integration, compliance, and revenue-cycle impact before you sign anything.
Key Takeaways
- Authorization services can cover automation, benefits investigation, documentation, status tracking, peer-to-peer coordination, and appeals.
- Fit hinges on payer mix, EHR and pharmacy workflows, OPAT volume, staffing model, and how much human intervention you will accept.
- Compare turnaround time, denial prevention, specialty-drug support, HIPAA safeguards, and integration before you contract.
- Verify vendor claims on savings, approval rates, and speed against your documentation and results.
Overview of Authorization Services in Infectious Disease Practices
Prior authorization isn't the same as eligibility verification, benefits investigation, or claims follow-up. CMS defines Medicare prior authorization specifically as a request for provisional coverage affirmation before a service is furnished.
Eligibility checks confirm active coverage. Utilization management is often a broader review process. Revenue-cycle management covers the full claims-to-collections arc.
Infectious disease authorization sits at the intersection of all of these, and that's what makes it harder than a typical specialty.
Why ID Authorization Workflows Get Complicated
A single OPAT course can trigger multiple separate authorizations:
- The antimicrobial itself, which may fall under the medical or pharmacy benefit
- Infusion administration, billed differently depending on site of care
- Home health or skilled nursing coordination
- Supplies and nursing visits for extended courses
Each piece can require its own documentation, including culture and susceptibility results, treatment duration, and medical-necessity justification. A therapy plan built before the benefit type is confirmed often needs to be rebuilt mid-process, and that rework can consume entire days of staff time.
The Workflow, Start to Finish
- Referral or treatment plan arrives and gets triaged
- Benefits verification determines medical versus pharmacy coverage
- Clinical documentation is collected and submitted to the payer
- Status monitoring tracks the request through decision
- Approval, denial, or peer-to-peer review determines next steps
- Appeal, if needed, requires payer-specific documentation
Weak authorization workflows produce real costs: delayed treatment starts, cancelled infusion appointments, avoidable staff rework, and delayed reimbursement.
A 2020 study of outpatient parenteral antimicrobial therapy patients found that 59 of 200 (nearly 30%) experienced a discharge delay, with authorization issues cited as one contributing factor, according to research published on PubMed. That study didn't isolate the exact share caused by authorization alone. Practices need their own tracking rather than relying on industry averages.
The five services below take different approaches: some are broad payer-facing platforms, some focus narrowly on medication access, and others depend heavily on payer participation. None should be assumed to cover infectious disease workflows without direct verification.
Top Authorization Services for Infectious Disease Practices
We evaluated each option on:
- Infectious disease and specialty-medication relevance
- Workflow coverage, payer connectivity, and EHR or pharmacy integration
- Documentation support and appeal capabilities
- Security posture, implementation burden, and pricing transparency
Availity
Availity Essentials lets providers check prior authorization requirements, initiate requests, attach documentation, and track pending cases across payers. Essentials Pro adds in-workflow submission and status tracking directly from the practice's existing system.
Best fit: Practices juggling many payers that want one portal for authorization status rather than logging into a dozen payer sites separately.
Relevant capabilities:
- Authorization initiation, documentation attachment, and status tracking
- Hundreds of practice-management, HIS, and EMR integrations documented by the vendor
- A 2023 case study demonstrating FHIR-based authorization with athenahealth and Humana
- SOC 2 and HITRUST-aligned security documentation
Key considerations: Availity's network page cites more than 2,700 payers and over 1 million providers, but that aggregate number doesn't confirm authorization availability for every drug or infusion service you bill. Basic Essentials access appears free; Pro-tier pricing isn't published, so confirm costs directly.
The platform doesn't explicitly document OPAT or infusion-specific workflows, so test that before relying on it for those cases.
Waystar
Waystar's Authorization Manager checks payer rules against orders from your EHR, PM, or HIS system, flags when authorization is needed, and surfaces at-risk accounts before claims go out.
Best fit: Larger practices or health-system-affiliated groups already using Waystar (or considering it) for broader revenue-cycle functions like eligibility, claims, and denials.
Relevant capabilities:
- Automated authorization-requirement checks tied to orders
- Worklists and status updates for pending cases
- Open APIs and EHR/PM integration, though the vendor doesn't name every supported system
- General RCM analytics (60+ reports, 12 dashboards) covering broader revenue-cycle metrics, not authorization-specific outcomes alone
Key considerations: A February 2025 vendor release reported a 70% reduction in submission time and 85% auto-approval for implemented Auth Accelerate clients. That's a self-reported result from a specific client group, not a controlled study, so treat it as directional.
The authorization product page doesn't explicitly call out OPAT, infusion, or antimicrobial billing support.
Experian Health
Experian Health's authorization product handles inquiry, payer data entry, and submission tracking, and it connects with the company's separate eligibility and denial-management tools.
Best fit: Practices that want authorization connected to eligibility checks and denial analytics in one vendor relationship, particularly larger groups with dedicated revenue-cycle staff.
Relevant capabilities:
- Authorization inquiry and submission with EHR and billing-system integration
- Separate eligibility verification for active coverage and plan benefits
- Predictive claim-denial and denial-triage tools (claims-focused, not authorization-approval tools)
Key considerations: A November 2025 case study on MetroHealth reported authorization volume growing from 2,200 to 6,000 monthly transactions, with processing time dropping from 10 minutes to under 4. That's one client's reported outcome, not a benchmark for infectious disease practices.
The product documentation doesn't spell out infusion or OPAT-specific functionality, so ask directly during a demo.
CoverMyMeds
CoverMyMeds focuses on electronic prior authorization for medications, covering both pharmacy-benefit and some medical-benefit workflows, with status tracking saved to the patient record.
Best fit: Practices needing fast pharmacy-benefit authorization for oral antimicrobials or specialty prescriptions, not full medical-benefit or infusion authorization.
Relevant capabilities:
- Electronic prior authorization with procedure-code and payer-requirement checks
- Status tracking and follow-up visible to prescribers
- Reported 950,000+ providers and 350+ EHR integrations (aggregate figures, not payer-specific guarantees)
Key considerations: CoverMyMeds' own payer and PBM page labels non-drug prior authorization as "launching H1 2026" at the time of review. That means medical-benefit authorization (the kind infusion and OPAT courses often require) may not be fully available yet. Confirm current status directly rather than assuming coverage.
The platform doesn't document infusion administration or home-health coordination, so it works best alongside another tool for those pieces.
Cohere Health
Cohere operates as a utilization-management platform that health plans adopt, meaning its availability to your practice depends entirely on whether your patients' payers have contracted with Cohere.
Best fit: Practices treating patients covered by plans that have already delegated utilization management to Cohere, such as select Humana or Geisinger products.
Relevant capabilities:
- Provider portal registration, which Cohere says takes under 10 minutes
- AI-supported appeal workflows
- Documented specialty categories including musculoskeletal, cardiology, imaging, sleep, and GI
Key considerations: No infectious disease, OPAT, or infusion line appears in Cohere's published specialty list. Peer-to-peer routing can vary by payer and service line, as Geisinger's own provider instructions note.
Registering for the portal doesn't mean a specific payer has delegated your OPAT or infusion authorizations to Cohere; that depends on the plan, not the practice.
How We Chose the Best Authorization Services
Vendor comparisons are only useful if they're grounded in verifiable product details rather than marketing copy. Here's the process we followed, and what we recommend practices do themselves.
Specialty fit comes first. Ask whether a service actually supports your authorization mix:
- OPAT and infusion therapy
- Specialty antimicrobials
- Home infusion and skilled nursing
- Durable medical equipment
- Medical- and pharmacy-benefit requests
A tool built for oncology or imaging authorizations may not translate cleanly to infectious disease.
Measure workflow performance with your own numbers. Track:
- Submission-to-decision time
- Pending-case volume at any given moment
- Staff minutes spent per authorization
- Approval and denial patterns by payer
- Appeal outcomes and treatment delays caused specifically by authorization
Vendor-reported benchmarks, like the case studies cited above, describe specific client environments. They're not guarantees for your practice.
Check the technical and operational fit:
- EHR or practice-management integration
- Payer connectivity for your actual payer mix
- Document-collection workflow and audit trails
- Contingency plans when the system goes down
Review the contract details:
- Implementation fees and per-transaction or subscription pricing
- Renewal terms and HIPAA business-associate obligations
- Pilot access or references from comparable practices
Regulatory context matters here too. The 2024 CMS interoperability rule sets decision timeframes for certain payers, including 72 hours for expedited requests and seven calendar days for standard non-drug requests.
It excludes drug authorizations and federally facilitated exchange plans, according to CMS's final rule fact sheet. That distinction matters for specialty antimicrobials, which often fall outside these timeframes.
Common mistakes to avoid:
- Picking a vendor on brand recognition alone
- Assuming one platform covers every authorization type your practice bills
- Overlooking payer-specific gaps, like Cohere's plan-by-plan availability
- Never defining which staff member owns a given authorization
- Counting approvals without tracking treatment delays or revenue impact
Before comparing vendor proposals, map your own authorization volume, payer mix, service lines, and denial reasons. GrowInfectiousDisease publishes free tools, including an Infusion & OPAT Economics Calculator and a Payer & Drug Authorization Lookup directory, built specifically to help infectious disease practices understand these mechanics using their own numbers rather than industry averages.
Conclusion
Fit matters more than platform size. The right authorization service matches your payers, treatment pathways, documentation burden, and staffing model.
Before signing a contract, check the vendor against how your practice actually works:
- Run a workflow demonstration on your actual authorization types
- Review the contract for pricing, support, and security terms
- Pilot the tool if possible
- Measure results against your own baseline, not vendor marketing claims
GrowInfectiousDisease's free, ungated resources exist precisely for that baseline work: understanding how authorization delays, denial patterns, and site-of-care decisions affect the financial sustainability of an independent infectious disease practice.
Frequently Asked Questions
What should an infectious disease practice look for in a prior authorization service?
Evaluate payer coverage for your drug and service mix, OPAT and infusion support, and documentation workflows. Also weigh EHR integration, status tracking, appeal support, HIPAA safeguards, implementation effort, and financial outcomes you can measure in your own practice.
Can a prior authorization platform handle both pharmacy and medical-benefit authorizations?
It depends on the vendor. Some tools focus only on pharmacy-benefit prescriptions, while others cover medical services or sit inside broader revenue-cycle platforms. Confirm coverage for your drugs, infusion services, payers, and sites of care before assuming one tool handles both.
